PubRank

A P Monaco

Author PubWeight™ 391.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987 16.01
2 The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988 10.75
3 A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001 9.25
4 Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986 6.45
5 Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature 1986 6.34
6 Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol 1966 5.59
7 Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A 1985 5.50
8 Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 1985 4.62
9 Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol 1966 4.49
10 Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 1986 4.13
11 Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 1993 3.63
12 An improved method for isolation of mouse pancreatic islets. Transplantation 1985 3.52
13 LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry 2007 3.49
14 Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet 1999 3.25
15 Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000 2.96
16 The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet 1998 2.91
17 Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. Proc Natl Acad Sci U S A 1991 2.89
18 Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet 1987 2.64
19 Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science 1965 2.41
20 A quantitative-trait locus on chromosome 6p influences different aspects of developmental dyslexia. Am J Hum Genet 1999 2.38
21 Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995 2.38
22 Localisation of a gene implicated in a severe speech and language disorder. Nat Genet 1998 2.33
23 Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet 1973 2.22
24 Construction, arraying, and high-density screening of large insert libraries of human chromosomes X and 21: their potential use as reference libraries. Proc Natl Acad Sci U S A 1991 2.21
25 Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation 1987 2.14
26 A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell 1986 2.12
27 A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics 1988 2.04
28 Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. JAMA 1973 1.94
29 Complete coverage of the Schizosaccharomyces pombe genome in yeast artificial chromosomes. Nat Genet 1992 1.93
30 Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976 1.84
31 Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science 1966 1.81
32 Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997 1.79
33 Two hundred one consecutive living-donor nephrectomies. Arch Surg 1998 1.75
34 Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet 2005 1.74
35 A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 2001 1.69
36 Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects. Behav Genet 2010 1.67
37 Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science 1987 1.66
38 Analysis of the human VPS13 gene family. Genomics 2004 1.65
39 A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999 1.65
40 Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994 1.65
41 FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am J Hum Genet 2002 1.63
42 Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation 1967 1.62
43 Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum 1965 1.60
44 The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am J Hum Genet 2000 1.60
45 Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br 2004 1.57
46 Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet 2002 1.56
47 Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry 2006 1.54
48 Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation 1988 1.52
49 Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet 1990 1.51
50 Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery 1988 1.50
51 A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996 1.47
52 Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 2003 1.47
53 Genetic and phenotypic effects of phonological short-term memory and grammatical morphology in specific language impairment. Genes Brain Behav 2007 1.46
54 High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry 2009 1.45
55 McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001 1.45
56 Controversies in organ donation: the altruistic living donor. Nephrol Dial Transplant 2001 1.45
57 Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005 1.38
58 Autism: recent molecular genetic advances. Hum Mol Genet 2000 1.34
59 Isolation of the human Xp21 glycerol kinase gene by positional cloning. Hum Mol Genet 1993 1.34
60 Genetic advances in the study of speech and language disorders. Neuron 2010 1.33
61 Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet 1999 1.31
62 High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression. Transplant Proc 1973 1.31
63 DNA linkage analysis of X chromosome-linked chronic granulomatous disease. Proc Natl Acad Sci U S A 1986 1.27
64 Characterization of the exon structure of the Menkes disease gene using vectorette PCR. Genomics 1995 1.26
65 Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region. Nat Genet 1992 1.25
66 Heterologous antilymphocyte sera and some of their effects. Transplantation 1967 1.25
67 Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 1997 1.23
68 A contig of non-chimaeric YACs containing the spinal muscular atrophy gene in 5q13. Hum Mol Genet 1993 1.23
69 Construction and characterization of a 10-fold genome equivalent rat P1-derived artificial chromosome library. Genomics 1998 1.22
70 Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1992 1.22
71 Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 1970 1.22
72 Putative functional alleles of DYX1C1 are not associated with dyslexia susceptibility in a large sample of sibling pairs from the UK. J Med Genet 2004 1.22
73 Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene. Hum Mol Genet 1997 1.21
74 Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet 2000 1.20
75 A Golgi localization signal identified in the Menkes recombinant protein. Hum Mol Genet 1998 1.20
76 Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow. Transplant Proc 1973 1.20
77 Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001 1.19
78 A technique for reconstruction of the urinary tract in renal transplantation. Surg Gynecol Obstet 1966 1.19
79 Three genes that escape X chromosome inactivation are clustered within a 6 Mb YAC contig and STS map in Xp11.21-p11.22. Hum Mol Genet 1995 1.19
80 Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3). Genomics 1999 1.19
81 Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet 1992 1.17
82 Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971 1.16
83 2.6 Mb YAC contig of the human X inactivation center region in Xq13: physical linkage of the RPS4X, PHKA1, XIST and DXS128E genes. Hum Mol Genet 1993 1.15
84 Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. Am J Hum Genet 1997 1.15
85 Immunosuppressive effects of an interferon preparation in vivo. Transplantation 1974 1.14
86 Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci U S A 1992 1.14
87 Self-injection of amphetamine directly into the brain. Psychopharmacology (Berl) 1983 1.13
88 Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci U S A 1995 1.13
89 Protective Effect of Antilymphocyte Serum on Mice Infected with Plasmodium berghei. Science 1969 1.13
90 Report and abstracts of the Fifth International Workshop on Human X Chromosome Mapping 1994. Heidelberg, Germany, April 24-27, 1994. Cytogenet Cell Genet 1994 1.11
91 The utrophin and dystrophin genes share similarities in genomic structure. Hum Mol Genet 1993 1.10
92 Aortoiliac reconstruction following renal transplantation. Surgery 1982 1.09
93 Recombination with pERT87 (DXS164) in families with X-linked muscular dystrophy. Lancet 1986 1.09
94 Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J Immunol 2001 1.08
95 Detection of a new submicroscopic Norrie disease deletion interval with a novel DNA probe isolated by differential Alu PCR fingerprint cloning. Cytogenet Cell Genet 1993 1.08
96 Molecular cloning and analysis of the fragile X region in man. Nucleic Acids Res 1991 1.08
97 Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1) Hum Mol Genet 1994 1.07
98 Analysis of reelin as a candidate gene for autism. Mol Psychiatry 2003 1.05
99 Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Hum Genet 1998 1.04
100 Cloning the Wilson disease gene. Nat Genet 1993 1.04
101 Identification of a di-leucine motif within the C terminus domain of the Menkes disease protein that mediates endocytosis from the plasma membrane. J Cell Sci 1999 1.04
102 Report and abstracts of the Fourth International Workshop on Human X Chromosome Mapping 1993. St. Louis, Missouri, May 9-12, 1993. Cytogenet Cell Genet 1993 1.03
103 Immunological characteristics of purified pancreatic islet grafts. Transplantation 1986 1.03
104 Retrofitting vectors for Escherichia coli-based artificial chromosomes (PACs and BACs) with markers for transfection studies. Genome Res 1997 1.03
105 The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. Genomics 1998 1.02
106 Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses. Eur J Hum Genet 2000 1.02
107 X-linked mixed deafness (DFN3): cloning and characterization of the critical region allows the identification of novel microdeletions. Hum Mol Genet 1994 1.02
108 Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991 1.02
109 Analysis of dyslexia candidate genes in the Raine cohort representing the general Australian population. Genes Brain Behav 2010 1.02
110 Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med 1992 1.02
111 Pancreas divisum. Results of surgical intervention. Am J Surg 1983 1.01
112 Destruction of splenic transplantation antigens by a factor present in liver. J Immunol 1965 1.01
113 Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol 1981 1.00
114 Use of minimal doses of lymphoid cells for production of heterologous antilymphocyte serum. Transplant Proc 1971 1.00
115 Investigation of quantitative measures related to reading disability in a large sample of sib-pairs from the UK. Behav Genet 2001 1.00
116 Isolation of CA dinucleotide repeats close to D6S105; linkage disequilibrium with haemochromatosis. Hum Mol Genet 1994 0.99
117 An unusual case of splenic abscess and sepsis in an immunocompromised host. Am J Clin Pathol 1987 0.99
118 Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am J Hum Genet 1995 0.99
119 Mutations and phenotype in isolated glycerol kinase deficiency. Am J Hum Genet 1996 0.99
120 Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects. Mol Psychiatry 2004 0.98
121 Successful treatment of Pneumocystis carinii and Nocardia asteroides in a renal transplant patient. Am J Med 1971 0.98
122 Construction of a human X-chromosome-enriched phage library which facilitates analysis of specific loci. Gene 1985 0.97
123 Genome-wide association analyses of child genotype effects and parent-of-origin effects in specific language impairment. Genes Brain Behav 2014 0.97
124 Fine-mapping of the spinal muscular atrophy locus to a region flanked by MAP1B and D5S6. Genomics 1992 0.97
125 Identifying autism susceptibility genes. Neuron 2000 0.97
126 Leukemia virus activation during homograft rejection. Science 1973 0.97
127 Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy families. J Med Genet 1986 0.95
128 Bivariate linkage scan for reading disability and attention-deficit/hyperactivity disorder localizes pleiotropic loci. J Child Psychol Psychiatry 2005 0.95
129 Survey of the current status of the clinical uses of antilymphocyte serum. Surg Gynecol Obstet 1976 0.95
130 The acquired immunodeficiency syndrome and transplantation. Transplantation 1987 0.95
131 A dinucleotide repeat polymorphism at the DMD locus. Nucleic Acids Res 1991 0.95
132 Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998 0.94
133 Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations. Mol Psychiatry 2007 0.94
134 DXS106 and DXS559 flank the X-linked dystonia-parkinsonism syndrome locus (DYT3). Genomics 1994 0.93
135 Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992 0.93
136 An integrated YAC map of the human X chromosome. Genome Res 1996 0.93
137 Cell mediated immunity (CMI) and post transplant viral infections--role of a functional immune assay to titrate immunosuppression. Int Immunopharmacol 2006 0.93
138 Graft-versus-host disease in fully allogeneic small bowel transplantation in the rat. Transplantation 1989 0.92
139 Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum. Surg Forum 1970 0.92
140 Contra-IL 2; a suppressor lymphokine that inhibits IL 2 activity. J Immunol 1986 0.92
141 A gene-based genetic linkage and comparative map of the rat X chromosome. Genomics 1997 0.91
142 Crucial role of pancreatic ductal collagenase injection for isolation of pancreatic islets. Horm Metab Res Suppl 1990 0.91
143 A sequence-ready physical map of a region of 12q24.1. Genomics 1997 0.91
144 Dystrophin, the protein product of the Duchenne/Becker muscular dystrophy gene. Trends Biochem Sci 1989 0.91
145 The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 1994 0.91
146 Characterization of the Menkes protein copper-binding domains and their role in copper-induced protein relocalization. Hum Mol Genet 1999 0.91
147 Genome-wide screening for DNA variants associated with reading and language traits. Genes Brain Behav 2014 0.91
148 Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998 0.90
149 Antilymphocyte globulins. Clinical use of antilymphocyte globulin. Transplant Proc 1977 0.90
150 Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacity. Clin Nephrol 2006 0.90
151 Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation 1991 0.90
152 Genome mapping and cloning of mutations using yeast artificial chromosomes. Methods Enzymol 1993 0.89
153 Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow. Transplantation 1986 0.89
154 Novel genes mapping to the critical region of the 5q- syndrome. Genomics 1997 0.89
155 Isolation of DNTR polymorphisms from yeast artificial chromosomes encompassing X chromosomal loci PGK1 and DXS56. Hum Genet 1992 0.88
156 Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Transplantation 1980 0.88
157 Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma. Eur J Hum Genet 1997 0.87
158 The isolation of cDNAs from OATL1 at Xp 11.2 using a 480-kb YAC. Genomics 1993 0.87
159 Mutation screening and imprinting analysis of four candidate genes for autism in the 7q32 region. Mol Psychiatry 2002 0.87
160 Characterization of a 1.0 Mb YAC contig spanning two chromosome breakpoints related to Menkes disease. Hum Mol Genet 1992 0.87
161 Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation 1989 0.87
162 Pulmonary fibrosis secondary to administration of mycophenolate mofetil. Transplantation 1998 0.86
163 A 2.8 Mb YAC contig in 11q12-q13 localizes candidate genes for atopy: Fc epsilon RI beta and CD20. Hum Mol Genet 1994 0.86
164 Construction of a YAC contig spanning the Xq13.3 subband. Genomics 1995 0.86
165 Problems in transplantation--ethics, education, and expansion. Transplantation 1987 0.86
166 Emergencies associated with clinical renal transplantation. Surg Clin North Am 1966 0.86
167 Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease. Arch Surg 1997 0.86
168 Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells. J Immunol 2000 0.86
169 Complications associated with immunosuppressive therapy and their management. Pharmacotherapy 1991 0.86
170 Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome. Somat Cell Mol Genet 1987 0.86
171 Generation of large insert YAC libraries. Methods Mol Biol 1996 0.86
172 Induction of graft-versus-host disease by small intestinal allotransplantation in rats. Transplantation 1985 0.86
173 Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther 1984 0.86
174 Effect of blood transfusion on IL-2 production. Transplantation 1988 0.85
175 Mycotic wound infections. A new challenge of the surgeon. Arch Surg 1979 0.85
176 Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci U S A 1991 0.85
177 Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. J Hum Genet 1999 0.85
178 Genome analysis and the human X chromosome. Science 1992 0.85
179 Effect of a single transfusion of donor-specific and nonspecific blood on skin allograft survival in mice. Transplantation 1980 0.85
180 Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions. J Immunol 1984 0.84
181 Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus. Transplantation 1998 0.84
182 Fine mapping of the human SCIDX1 locus at Xq12-13.1. Hum Mol Genet 1993 0.84
183 Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization. Hum Mol Genet 1992 0.84
184 Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 2000 0.84
185 A high-resolution interval map of the q21 region of the human X chromosome. Genomics 1995 0.84
186 Integrated physical and transcript map of 5q31.3-qter. Eur J Hum Genet 1998 0.83
187 A locus for an auditory processing deficit and language impairment in an extended pedigree maps to 12p13.31-q14.3. Genes Brain Behav 2010 0.83
188 Molecular studies of progressive muscular dystrophy (Duchenne). Enzyme 1987 0.83
189 The chorea of McLeod syndrome. Mov Disord 2001 0.83
190 Impairment of pulmonary bacterial defense mechanisms by immunosuppressive agents. Surg Forum 1970 0.83
191 Molecular genetics of Duchenne muscular dystrophy. Cold Spring Harb Symp Quant Biol 1986 0.83
192 Prolongation of skin allograft survival in H-2 K and I region-incompatible mice by pretransplant blood transfusion. Transplantation 1981 0.83
193 A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 1996 0.83
194 Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992 0.83
195 Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes 1996 0.83
196 Assignment of the gene (EPLG2) encoding a high-affinity binding protein for the receptor tyrosine kinase elk to a 200-kilobasepair region in human chromosome Xq12. Genomics 1995 0.83
197 Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21. Am J Hum Genet 1992 0.83
198 Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Transplantation 1997 0.83
199 Multiple donor allotransplantation. A new approach to pancreatic islet transplantation. Transplantation 1988 0.83
200 Autism, mental retardation, multiple exostoses and short stature in a female with 46,X,t(X;8)(p22.13;q22.1). Psychiatr Genet 1995 0.83
201 Expression of MHC class II antigen is essential in tolerance induction by donor bone marrow cell in antilymphocyte serum-treated and rapamycin-treated mice. Transplant Proc 2001 0.82
202 Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection. Transplant Proc 1971 0.82
203 Pancreatic islet transplantation using H-2 incompatible multiple donors. Transplant Proc 1987 0.82
204 HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc 1987 0.82
205 Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy. Neurogenetics 2001 0.82
206 Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion. Transplant Proc 1972 0.82
207 Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia. Genomics 2000 0.82
208 Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody. Transplantation 1972 0.82
209 Use of antilymphocyte serum in the induction of immunological tolerance to tissue allografts. Fed Proc 1970 0.82
210 Construction and characterization of yeast artificial chromosome libraries from the mouse genome. Methods Enzymol 1993 0.81
211 Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis. Clin Nephrol 1995 0.81
212 Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet 1997 0.81
213 Suppressor cells in mice bearing intact skin allografts after blood transfusions. Transplantation 1981 0.81
214 Physical mapping in a YAC contig of 11 markers on the human X chromosome in Xp11.23. Genomics 1994 0.81
215 Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 1997 0.81
216 Activation of C-type viruses during skin graft rejection in the mouse. Interrelationships between immunostimulation and immunosuppression. Int J Cancer 1975 0.81
217 Detection, breakpoint identification and detailed characterisation of a CNV at the FRA16D site using SNP assays. Cytogenet Genome Res 2009 0.81
218 Effect of antilymphocyte serum on crude pancreatic islet allograft survival. Transplant Proc 1987 0.80
219 The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice. Transplantation 1992 0.80
220 Minimum number of islets required to maintain euglycemia and their reduced immunogenicity after transplantation into diabetic mice. Transplantation 1993 0.80
221 Successful induction of increased resistance to gram-negative bacteria and to endotoxin in immunosuppressed mice. Am J Surg 1974 0.80
222 The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity. Transplant Proc 1969 0.80
223 The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice. Transplantation 1988 0.80
224 FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. Transplant Proc 1991 0.80
225 Dinucleotide repeat polymorphisms from DXS106 and DXS227 YACs using a two stage approach. Hum Mol Genet 1993 0.80
226 Assignment of genes encoding GABAA receptor subunits alpha 1, alpha 6, beta 2, and gamma 2 to a YAC contig of 5q33. Eur J Hum Genet 1996 0.79
227 A genome-wide search strategy for identifying quantitative trait loci involved in reading and spelling disability (developmental dyslexia). Eur Child Adolesc Psychiatry 1999 0.79
228 Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine. Transplantation 1995 0.79
229 Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin. Am J Surg 1984 0.79
230 Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations. Clin Transplant 1996 0.79
231 Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus. Clin Pharmacokinet 1995 0.79
232 Predictive value of pretransplant IL-2 levels in kidney transplantation. Transplant Proc 1991 0.79
233 Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint. Genes Chromosomes Cancer 1993 0.79
234 Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location. Cold Spring Harb Symp Quant Biol 1986 0.79
235 A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients. Arch Surg 1990 0.79
236 Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation. J Immunol 1982 0.79
237 The existence of graft-versus-host disease in long-term surviving fully allogeneic rat small bowel transplant recipients. Transplant Proc 1989 0.79
238 Response to paper by Molloy et al.: linkage on 21q and 7q in autism subset with regression. Mol Psychiatry 2006 0.79
239 Cryptosporidium infection in renal transplant patients. Clin Nephrol 2005 0.79
240 Porcine islets for xenotransplantation. Transplantation 1996 0.79
241 Mouse skin graft prolongation with donor-strain bone marrow and antilymphocyte serum. Effect of bone marrow cell storage. Transplantation 1986 0.78
242 Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. Am J Med 1980 0.78
243 Use of heterogenous and monospecific antisera for the diagnosis of bladder cancer. J Urol 1977 0.78
244 Immune reactivity in congenic mice after allogeneic or isogeneic transfusion. Transplantation 1986 0.78
245 Characterisation of an inverted X chromosome (p11.2q21.3) associated with mental retardation using FISH. J Med Genet 1998 0.78
246 Localization of tub and uncoupling proteins (Ucp) 2 and 3 to a region of rat chromosome 1 linked to glucose intolerance and adiposity in the Goto-Kakizaki (GK) type 2 diabetic rat. Mamm Genome 1998 0.78
247 Immunosuppression, interferon inducers, and leukemia in mice. Proc Soc Exp Biol Med 1970 0.78
248 Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow. Transplantation 1987 0.78
249 Recent progress in the genetics of human epilepsies. Neurogenetics 1998 0.78
250 Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 1991 0.78
251 Dystrophin expression and genotypic analysis of two cases of benign X linked myopathy (McLeod's syndrome). J Med Genet 1990 0.78
252 Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice. Transplantation 1991 0.78
253 Recent advances in the treatment of systemic mycotic infections. Surg Gynecol Obstet 1979 0.78
254 Genetic refinement and physical mapping of the CMT4B gene on chromosome 11q22. Genomics 2000 0.78
255 Enhancement of pancreatic islet allograft survival with ALS and donor bone marrow. Surg Forum 1974 0.78
256 Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin. Transplantation 1995 0.78
257 The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice. Transplantation 1977 0.78
258 Sequential interleukin 2 and interleukin 2 receptor levels distinguish rejection from cyclosporine toxicity in liver allograft recipients. Arch Surg 1991 0.78
259 Analysis of Mnk, the murine homologue of the locus for Menkes disease, in normal and mottled (Mo) mice. Genomics 1994 0.78
260 Possible mechanisms underlying marked islet allograft survival following multiple-donor allotransplantation. Transplant Proc 1991 0.78
261 The effect of supralethal amethopterin and folinic acid rescue on mouse skin allograft survival. Proc Soc Exp Biol Med 1971 0.78
262 Mechanism of augmented graft survival in mice after ALS and bone marrow infusion. Transplant Proc 1973 0.78
263 The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow. J Immunol 1977 0.78
264 Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Transplantation 1998 0.78
265 Effect of specific and nonspecific alloantigen stimulation on islet allograft survival. Transplant Proc 1989 0.78
266 Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum. Transplantation 1988 0.78
267 Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice. Transplant Proc 1978 0.77
268 Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments. Transplant Proc 1972 0.77
269 Resistance of established porcine islet xenografts to humoral rejection by hyperimmune sera. Transplantation 1999 0.77
270 Small bowel transplantation in rats using RS-61443: effect on GVHD and rejection. Transplant Proc 1992 0.77
271 A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996 0.77
272 Development of suppressor T cells by antilymphocyte serum treatment in mice. Transplantation 1982 0.77
273 Renal transplantation in the diabetic. World J Surg 1986 0.77
274 McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene. Mov Disord 2000 0.77
275 Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion. Transplant Proc 1996 0.77
276 Porcine islet xenotransplantation utilizing a vascularized bioartificial pancreas. Ann Transplant 1997 0.77
277 Gamma-irradiation as a tool to reduce immunogenicity of islet allo- and xenografts. Horm Metab Res Suppl 1990 0.77
278 Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells. Transplantation 2000 0.77
279 Molecular genetic investigations of autism. J Autism Dev Disord 1998 0.77
280 Pancreatic islet isografts in mice. Surg Forum 1973 0.77
281 Prolongation of skin allograft survival in antilymphocyte serum-treated mice by posttransplant administration of peripheral blood lymphocytes. Transplantation 1989 0.77
282 Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets. Transplant Proc 1991 0.77
283 Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Transplantation 1997 0.77
284 Strategies for autism candidate gene analysis. Novartis Found Symp 2003 0.77
285 Transplantation of the larynx--a case report that speaks for itself. N Engl J Med 2001 0.77
286 The effect of bacterial adjuvants on allograft survival after anti-lymphocyte serum (ALS) and donor bone marrow in mice. Immunology 1974 0.76
287 Urinary proteins as biological markers: bladder cancer diagnosis versus urinary tract infection. J Urol 1980 0.76
288 Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine, and porcine islets. Transplant Proc 1992 0.76
289 Amphetamine-induced overeating and overweight in rats. Life Sci 1981 0.76
290 Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine. Transplant Proc 1989 0.76
291 Transplantation of islet allografts using a diffusion-based biohybrid artificial pancreas: long-term studies in diabetic, pancreatectomized dogs. Transplant Proc 1993 0.76
292 Effect of cyclosporine A treatment on induction of donor specific unresponsiveness in mongrel dogs following a short course of ALS and donor bone marrow infusion on canine renal allograft function. Transplant Proc 1991 0.76
293 Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice. Transplant Proc 1979 0.76
294 Immunologic heterogeneity among potential transplant recipients. Prospects for predicting immune responses to allografts with in vitro tests. Clin Lab Med 1991 0.76
295 PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection. J Surg Res 1996 0.76
296 Contra-IL 2 activity of a lymphokine produced by a hybrid cell line of ALS-induced suppressor T cells. Transplant Proc 1987 0.76
297 Mouse skin graft prolongation with donor strain bone marrow and antilymphocyte serum. Effect of donor age. Transplantation 1985 0.76
298 High-resolution comparative mapping of the proximal region of the mouse X chromosome. Genomics 1995 0.76
299 Covering YAC-cloned DNA with phages and cosmids. Methods Mol Biol 1996 0.76
300 Augmented survival of purified islet xeno- and allografts with reduced numbers. Transplant Proc 1987 0.76
301 Prevention of graft-versus-host disease by RS-61443 in two different rodent models. Transplantation 1993 0.76
302 Modification of the immunosuppressive effects of rabbit antimouse lymphocyte serum by a thymic humoral factor: thymosin. Surg Forum 1969 0.76
303 Use of Dacron cuffed silicone catheters as long-term hemodialysis access. ASAIO J 1992 0.75
304 A 2-Mb YAC contig encompassing three loci (DXF34, DXS14, and DXS390) that lie between Xp11.2 translocation breakpoints associated with incontinentia pigmenti type 1. Genomics 1994 0.75
305 Immunological detection of human bladder carcinoma. Ann Surg 1975 0.75
306 Genomic organization of the human galpha14 and Galphaq genes and mutation analysis in chorea-acanthocytosis (CHAC). Genomics 1999 0.75
307 The biohybrid artificial pancreas for treatment of diabetes in totally pancreatectomized dogs. Transplant Proc 1991 0.75
308 Refined genetic mapping of the darier locus to a <1-cM region of chromosome 12q24.1, and construction of a complete, high-resolution P1 artificial chromosome/bacterial artificial chromosome contig of the critical region. Am J Hum Genet 1998 0.75
309 Effect of early administration of donor bone marrow cells on renal allograft survival in dogs treated with antilymphocyte serum and cyclosporine. Transplantation 1995 0.75
310 X linked Charcot-Marie-Tooth disease (CMTX1): a study of 15 families with 12 highly informative polymorphisms. J Med Genet 1994 0.75
311 Early treatment of diabetes with porcine islets in a bioartificial pancreas. Tissue Eng 1996 0.75
312 The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs. Transplantation 1991 0.75
313 Successful treatment of experimental diabetes by sequential transplantations of multiple-donor pancreatic islet allografts. Transplantation 1989 0.75
314 Correlation between urine sediment cytology analysis and clinical state in cyclosporine-treated renal recipients. Transplant Proc 1987 0.75
315 Induction of unresponsiveness to skin allografts with donor-strain platelets in antilymphocyte-serum-treated mice. Transplant Proc 1979 0.75
316 Effect of blood transfusion on skin allograft survival in immunosuppressed mice. Transplant Proc 1981 0.75
317 Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice. Transplant Proc 1989 0.75
318 The effects of antilymphocyte serum and cyclosporine on orthotopic small bowel allografts in the rat. Transplant Proc 1988 0.75
319 Protective effect of antilymphocyte serum on mice infected with Plasmodium berghei. Science 1969 0.75
320 Case report: immunosuppressive therapy following Cryptococcal meningitis. Postgrad Med 1976 0.75
321 Etiology of early renal allograft dysfunction after live donor renal transplantation. Transplant Proc 1998 0.75
322 Lymphokine determinations for monitoring the renal allograft. Transplant Proc 1989 0.75
323 Multiple nonspecific blood transfusions prolong skin allograft survival in immunosuppressed mice. Proc Clin Dial Transplant Forum 1979 0.75
324 BCG immunotherapy: effects of dose and route of administration in mice bearing established tumors. Surg Forum 1976 0.75
325 Antithymocyte globulin, pretransplant blood transfusion, and tissue typing in cadaver kidney transplantation. Am J Surg 1983 0.75
326 Tolerance after transiently placed H-2 grafts. Transplantation 1969 0.75
327 Detection of bladder-cancer-associated antigens in urine by micro-complement fixation. Surg Forum 1974 0.75
328 Studies on heterologous antilymphocyte serum in mice. V. Effect of prior administration of normal or antilymphocyte rabbit gamma-globulin. Transplantation 1970 0.75
329 Identification of cell population mediating suppression after blood transfusion. Transplant Proc 1987 0.75
330 Differential effect of cyclophosphamide on states of specific allograft unresponsiveness in immunosuppressed mice. Transplantation 1979 0.75
331 Laparoscopic versus open donor nephrectomy. Kidney Int 2000 0.75
332 Toxic shock syndrome complicating orthotopic liver transplantation--a case report. Transplantation 1986 0.75
333 Effects of pyran copolymer on oncogenic virus infections in immunosuppressed hosts. J Immunol 1972 0.75
334 Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow. Transplant Proc 1987 0.75
335 Modification of immunosuppressive effects of antilymphocyte serum by a thymic humoral factor, thymosin. Br J Surg 1969 0.75
336 Combined kidney and pancreas transplantation. A 3-year experience. Arch Surg 1992 0.75
337 An enzyme immunoassay for urinary C-reactive protein. Diagn Immunol 1983 0.75
338 Progression of peripheral vascular disease after combined kidney-pancreas transplantation in diabetic patients with end-stage renal failure. Transplant Proc 1997 0.75
339 Primers for the dinucleotide repeat at the DXS453 locus also recognizes the DXS983 locus. Hum Mol Genet 1993 0.75
340 Histologic response to OKT3 therapy for hepatic allograft rejection. Transplant Proc 1987 0.75
341 Synergy between spleen cells and bone marrow cells in mixed lymphocyte culture-induced cytotoxicity. Requirement for macrophages in the induction of synergy. Cell Immunol 1980 0.75
342 Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice. Transplant Proc 1993 0.75
343 Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation. Am J Surg 1987 0.75
344 Generation of large insert yeast artificial chromosome libraries. Mol Biotechnol 1997 0.75
345 Monitoring the renal allograft by immunofluorescence of tubular epithelial cells in the urine sediment. Transplant Proc 1984 0.75
346 Active enhancement of tissue allografts with antilymphocyte serum and bone marrow. Adv Nephrol Necker Hosp 1975 0.75
347 Mouse skin allograft model for study of pregraft blood transfusion. Transplant Proc 1982 0.75
348 Studies on heterologous antilymphocyte serum in mice. IX. In vitro assay by indirect leukoagglutination. Transplantation 1972 0.75
349 Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice. Transplant Proc 1987 0.75
350 A sibling-pair based approach for mapping genetic loci that influence quantitative measures of reading disability. Prostaglandins Leukot Essent Fatty Acids 2000 0.75
351 The effect of timing of multiple donor-specific or nonspecific blood transfusions on skin allograft survival in ALS-treated mice. Transplantation 1983 0.75
352 Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model. Transplantation 1995 0.75
353 Analysis of donor reactive cells in ALS-treated mice bearing skin allografts after the intrathymic injection of donor specific spleen cells. Transpl Immunol 1995 0.75
354 In vitro antilymphocyte serum cell-binding affinity as indicator of in vivo immunosuppressive ability. Surg Forum 1972 0.75
355 Physical mapping of Xq24-25 around loci closely linked to the X-linked lymphoproliferative syndrome locus: an overlapping YAC map and linkage between DXS12, DXS42, and DXS37. Eur J Hum Genet 1993 0.75
356 The effect of blood transfusions on the immune response. Transplant Proc 1988 0.75
357 Steroids can be stopped in kidney transplant recipients. Transplant Proc 1981 0.75
358 Pancreatic islet transplantation using membrane diffusion chambers. Transplant Proc 1992 0.75
359 Essential role of MHC class II antigens in tolerance induction in allogeneic radiation chimera. Transplant Proc 2001 0.75
360 Prolonged survival of renal allografts in dogs treated with anti-lymphocyte serum. Surg Forum 1966 0.75
361 Cortical wave amplitude and eye movement direction are correlated in REM sleep but not in waking. Arch Ital Biol 1984 0.75
362 Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys. Transplant Proc 1987 0.75
363 Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture. Transplant Proc 1989 0.75
364 Letter: System for organ donation. N Engl J Med 1975 0.75
365 Replication errors may contribute to the generation of large deletions and duplications in the dystrophin gene. Hum Mutat 1992 0.75
366 Binding of antihuman globulin by exfoliated renal tubular cells following kidney transplantation. Transplantation 1985 0.75
367 Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats. Transplant Proc 1994 0.75
368 Detection of tumor-associated antigens in urine from patients with bladder cancer. J Urol 1980 0.75
369 Antilymphocyte globulin: a clinical transplantation research opportunity. Am J Kidney Dis 1982 0.75
370 Proceedings: active enhancement of mouse skin allografts: the effect of Bordetella pertussis and regional lymphadenectomy. Br J Surg 1974 0.75
371 Role of the thymus in allograft immunity. Adv Surg 1966 0.75
372 Implantation of a hybrid artificial pancreas in diabetic dogs. Transplant Proc 1992 0.75
373 Acquired tolerance for cardiac allografts. Surg Forum 1972 0.75
374 Studies on heterologous antilymphocyte serum in mice. IV. Modifications in the effects of antilymphocyte serum produced by prior adult thymectomy. Antibiot Chemother 1969 0.75
375 Effect of timing of bone marrow injection on the prolongation of skin grafts in ALS-treated mice. Transplant Proc 1989 0.75
376 Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow. Density gradient fractionation of the active bone marrow cells. Transplantation 1987 0.75
377 Role of cell-mediated immunity and serum blocking factors in states of immunologic unresponsiveness. Transplant Proc 1977 0.75
378 Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients. Transplant Proc 1991 0.75
379 Electronic identification and chromosomal assignment by radiation hybrid mapping of human expressed sequence tags corresponding to new potassium channel genes. Neurogenetics 1999 0.75
380 Transplantation for Chinese herb nephropathy. Clin Transpl 2006 0.75
381 The 1990 Peter Medawar Award. Transplant Proc 1991 0.75
382 Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study. Cancer Immunol Immunother 1986 0.75
383 Effects of pyran copolymer on leukemogenesis in immunosuppressed AKR mice. J Immunol 1973 0.75
384 Differential effect of adult thymectomy in mice treated with antilymphocyte or antithymocyte serum. Transplantation 1972 0.75
385 Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients. Transplant Proc 1999 0.75
386 De novo development of membranous nephropathy in cadaver renal allografts. Clin Nephrol 1978 0.75
387 Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice. Transplant Proc 1981 0.75
388 Keeping up with the Jones's: open donor nephrectomy in the laparoscopic era. Transplant Proc 2004 0.75
389 Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells. J Immunol 1985 0.75
390 Identification of a yeast artificial chromosome that spans the human papillary renal cell carcinoma-associated t(X;1) breakpoint in Xp11.2. Cancer Genet Cytogenet 1993 0.75
391 Effect of rapamycin on islet and skin xenograft survival. Transplant Proc 1993 0.75
392 Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival. Transplant Proc 1994 0.75
393 Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts. Surg Forum 1968 0.75
394 Renal homotransplantation: spectrum of angiographic findings of the kidney. Am J Roentgenol Radium Ther Nucl Med 1971 0.75
395 Construction of two YAC contigs in human Xp11.23-p11.22, one encompassing the loci OATL1, GATA, TFE3, and SYP, the other linking DXS255 to DXS146. Genomics 1995 0.75
396 Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities. Transplant Proc 1993 0.75
397 Successful renal transplantation in patients with circulating antibodies to glomerular basement membrane. Proc Clin Dial Transplant Forum 1973 0.75
398 Isolation of new probes from Xq12-->q13: an example of the screening of reference libraries with Alu-PCR products from radiation hybrids. Cytogenet Cell Genet 1992 0.75
399 Correlation of binding of human immunoglobulin, urinary cytology, and needle biopsy in the early posttransplant period. Transplant Proc 1987 0.75
400 [Renal allograft in the dog. A new method for survival prolongation]. Nouv Presse Med 1973 0.75
401 Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow. Surg Forum 1973 0.75
402 Pancreatic islet cell transplantation and diabetes therapy. Compr Ther 1976 0.75
403 A new in vitro assay for immunosuppressive potency of antilymphocyte serum. Transplant Proc 1972 0.75
404 Cytologic examination of urinary sediment in renal allograft recipients. Transplant Proc 1989 0.75
405 Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts. Transplant Proc 1993 0.75
406 Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum. Transplant Proc 1987 0.75
407 Effect of cyclosporin A supplementation and on renal allograft survival in ALS plus bone marrow treated dogs. Transplant Proc 1989 0.75
408 Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants. Transplant Proc 1997 0.75
409 Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus. Transplant Proc 1998 0.75
410 The immunologically privileged site for islet cell transplantation. Transplant Proc 1989 0.75
411 Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model. Transplant Proc 1994 0.75
412 A small deletion in the Duchenne/Becker muscular dystrophy locus--a functionally important region? Hum Genet 1987 0.75
413 Identification of YAC and cosmid clones encompassing the ZFX-POLA region using irradiation hybrid cell lines. Genomics 1994 0.75
414 Long-term function of porcine islets in xenogeneic hosts. Transplant Proc 1996 0.75
415 Chronic rejection and suboptimal immunosuppression. Transplant Proc 1993 0.75
416 Immunohistology of liver allografts in recipients managed with prophylactic OKT3. Transplant Proc 1989 0.75
417 OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc 1995 0.75
418 Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. Transplant Proc 1996 0.75
419 Regulation of the activity of graft survival-prolonging bone marrow cells. Transplant Proc 1989 0.75
420 In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts. Transplant Proc 1981 0.75
421 Prolongation of skin allograft survival in immunosuppressed mice by multiple transfusions of nonspecific blood. Transplantation 1980 0.75
422 Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine. Transplant Proc 1996 0.75
423 A single-center experience with six-antigen-matched kidney transplants. Arch Surg 1995 0.75
424 Two polymorphic dinucleotide repeats in the rat dystrophin gene, including the conserved 3' UTR repeat. Mamm Genome 1995 0.75
425 In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice. Transplant Proc 1973 0.75
426 Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients. Transplant Proc 1989 0.75
427 Survival of canine renal allografts after antilymphocytic serum and bone-marrow treatment. Br J Surg 1972 0.75
428 Metabolic effects of systemic versus portal venous drainage of orthotopic small bowel isografts. Transplant Proc 1989 0.75
429 Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. I. Effect of donor-specific bone marrow in ALS-treated mice. Transplantation 1984 0.75
430 Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice. Transplantation 1995 0.75
431 Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. II. Effect of pre-graft donor-specific blood transfusions in ALS-treated mice. Transplantation 1984 0.75
432 Four dinucleotide repeat polymorphisms at the D7S804 locus. Hum Mol Genet 1993 0.75
433 Simultaneous procurement of pancreas and liver from a single cadaveric donor. Transplant Proc 1989 0.75
434 Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up. Arch Surg 1995 0.75
435 Immunoprotection provided by the bioartificial pancreas in a xenogeneic host. Transplant Proc 1997 0.75
436 Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). Transplantation 1995 0.75
437 Induction of cytotoxic (sensitization) and enhancing (prolonged survival) responses by injection of lymphoid cells in ALS-treated mice. Transplant Proc 1979 0.75
438 Indirect leukoagglutination: an in vitro assay for antilymphocyte serum. Surg Forum 1971 0.75
439 Suppression of cell-mediated immunity by a donor-transmitted lymphocytic choriomeningitis virus in a kidney transplant recipient. Transpl Infect Dis 2007 0.75
440 Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice. Transplantation 1979 0.75
441 Renal allograft loss due to proximal extension of ileofemoral deep venous thrombosis. Clin Transplant 2002 0.75
442 Urine sediment cytology in the management of renal allograft recipients. Transplant Proc 1989 0.75
443 Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression. Transplant Proc 1992 0.75
444 Genome maps III. 1992. Wall Chart. Science 1992 0.75
445 Effect of gamma-irradiation on mouse pancreatic islet-allograft survival. Diabetes 1989 0.75
446 Cadaver donor hyperglycemia does not impair long-term pancreas allograft survival or function. Transplant Proc 1994 0.75
447 Evaluation of the hybrid artificial pancreas in diabetic dogs. ASAIO J 1992 0.75
448 [A new technic for obtaining bone marrow from living dogs]. Biomedicine 1973 0.75
449 Antilymphocyte serum and cell-free antigen loading. Transplantation 1969 0.75
450 A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation. Transplant Proc 2002 0.75
451 Successful renal transplantation in patients with circulating antibody to glomerular basement membrane: report of two cases. Clin Nephrol 1974 0.75
452 Models of specific unresponsiveness in adult animals: potential clinical application. Transplant Proc 1981 0.75
453 Progress in clinical organ transplantation. Surg Annu 1971 0.75
454 Tumor-associated antigens in the urine of patients with bladder cancer. Cancer Res 1982 0.75
455 Islet transplantation using an immunoprotective membrane in dogs that have undergone a pancreatectomy. ASAIO J 1993 0.75
456 Retroperitoneal renal and intraperitoneal pancreatic transplantation. J Am Coll Surg 1994 0.75
457 Transplantation. Surg Gynecol Obstet 1975 0.75
458 A comprehensive approach to organ donation. Hosp Pract (1995) 1997 0.75
459 Further studies on the in vitro assay of immunosuppressive potency of antilymphocyte serum by the mixed agglutination technique. Transplant Proc 1973 0.75
460 Generalized seizures associated with the use of muromonab-CD3 in two patients after kidney transplantation. Ann Pharmacother 1997 0.75
461 Combined liver and whole pancreas procurement in donors with a replaced right hepatic artery. Surg Gynecol Obstet 1992 0.75
462 BCG immunotherapy: effects of dose and route of administration on survival of mice bearing established tumors. J Surg Oncol 1978 0.75
463 Bone marrow cells that prolong graft survival in ALS-treated mice: characterization for markers related to lymphocyte ontogeny. Transplant Proc 1989 0.75
464 Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection. Transplant Proc 1989 0.75
465 Immunosuppression and renal transplantation. Nephron 1987 0.75
466 Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients. Ann Pharmacother 1992 0.75
467 Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation. Transplant Proc 2005 0.75
468 Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice. Transplantation 1980 0.75